Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Unknown 5Completed 2Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Pancreatic Neoplasms 1Neoplasms 1Neoplasm Metastasis 1Gastrointestinal Diseases 1Esophageal Squamous Cell Carcinoma 1

Interventions

Fluorouracil 616Oxaliplatin 579Gemcitabine 492Capecitabine 445Leucovorin 427Irinotecan 390Bevacizumab 331Cisplatin 320Radiotherapy 245Cetuximab 215Sorafenib 167pembrolizumab 152Docetaxel 150Paclitaxel 140Nivolumab 128Albumin-Bound Paclitaxel 108130-nm albumin-bound paclitaxel 108Folfox protocol 101Panitumumab 95Erlotinib Hydrochloride 95Surgical Procedures, Operative 86regorafenib 84S 1 (combination) 81Drug Therapy 80Radiation 69Carboplatin 65Neoadjuvant Therapy 64Colonoscopy 64Radiosurgery 63Surveys and Questionnaires 60

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × huachansu × Gastrointestinal × Clear all
NCT02647125 2024-11-26

A Study of Comparing Huachansu Plus Thoracic RT Versus RT Alone For ESCC

Fudan University

Phase 2 Completed
126 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT00837239 2012-07-12

Huachansu & Gemcitabine in Pancreatic Cancer

M.D. Anderson Cancer Center

Phase 2 Completed
80 enrolled
Gastrointestinal

Gastrointestinal Diseases, Neoplasm Metastasis, Neoplasms, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡